News | Robotic Systems | November 07, 2023

Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States

the first patients in the United States have been treated successfully utilizing Abbott’s EnSite X EP System integrated with Stereotaxis’ Robotic Magnetic Navigation System

November 7, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced the first patients in the United States have been treated successfully utilizing Abbott’s EnSite X EP System integrated with Stereotaxis’ Robotic Magnetic Navigation System

The integration of Abbott’s leading cardiac mapping system and Stereotaxis’ advanced robotic technology, first announced at Heart Rhythm 2023, combines highly detailed real-time diagnostic information with the unprecedented precision and stability of robotics during therapy delivery. The first integrated procedures in the US were completed by physicians at Weill Cornell Medical Center, Mount Sinai Morningside, Banner University Medical Center Phoenix, and Overland Park Regional Medical Center

“We are very pleased with how well these initial procedures went and the progress toward open interoperability with robotics in electrophysiology,” said Dr. Dhanunjaya Lakkireddy, Electrophysiologist and Executive Medical Director of Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center. “Combining Abbott’s leading cardiac mapping system with Stereotaxis’ advanced robotic technology enhances precision and streamlines procedure workflow, ultimately benefiting the patients we are dedicated to treating.” 

“Abbott and Stereotaxis have each played leading roles in advancing care for the most complex and difficult to treat arrhythmia patients,” added Dr. Jim Cheung, Associate Director of Cardiac Electrophysiology at Weill Cornell Medical Center. “We are delighted to be able to use both technologies in an integrated fashion, leveraging the combined benefits in diagnosis and therapy for our patients.” 

“As long-term users of both Abbott and Stereotaxis technology, we appreciate the ability to use these technologies together with a smooth integrated workflow,” said Dr. Ranjit Suri, Professor of Medicine at the Icahn School of Medicine at Mount Sinai. “Increased physician choice and technology interoperability benefits patients, physicians and providers.” 

“The success of these procedures demonstrates the unmatched potential and importance of increased collaboration in the field of electrophysiology,” added Dr. J. Peter Weiss, Director of Ventricular Arrhythmia Management and Robotics at Banner University Medicine Heart Institute. “The combined benefits of advanced mapping and robotic technologies allows us to envision a new era of cardiac care where personalized therapy is designed and delivered to each individual patient. It's a game-changer for the field." 

For more information: 


Related Content:  

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms  

Abbott Announces U.S. and European Approvals for New Technologies to Support Effective Treatment for Abnormal Heart Rhythms  

FDA Clears New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms 

Related Content

News | HRS

September 21, 2023 — Vektor Medical, developers of the only FDA-cleared technology to accurately map arrhythmias using ...

Home September 21, 2023
Feature | HRS | By Melinda Taschetta-Millane

The Heart Rhythm Society (HRS) announced the full lineup of speakers and sessions, including late-breaking clinical ...

Home May 17, 2023
News | HRS

May 2, 2023 — The Heart Rhythm Society (HRS) is making final preparations for its Annual Heart Rhythm Meeting, HRS2023 ...

Home May 02, 2023
Feature | HRS | By Lars Thording, PhD

Hospitals in the U.S. are suffering under a debilitating post-pandemic financial and operational trauma. Ascension ...

Home August 23, 2022
News | HRS

August 4, 2022 — The Heart Rhythm Society (HRS) is a professional society representing a diverse population of ...

Home August 04, 2022
News | HRS

May 17, 2022 — Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding ...

Home May 17, 2022
Videos | HRS

Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of ...

Home May 22, 2020
Feature | HRS

May 20, 2020 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them ...

Home May 20, 2020
Feature | HRS | Dave Fornell, Editor

May 15, 2019 — The Heart Rhythm Society (HRS) had 21 late-breaking study presentations at the 2019 Heart Rhythm ...

Home May 15, 2019
Feature | HRS | Dave Fornell

Here is an aggregation of all the news and late-breaking studies presented at the 2018 Heart Rhythm Society (HRS) ...

Home May 18, 2018
Subscribe Now